Skip to main content
Terug
Watch Compare

Atea Pharmaceuticals, Inc.

Datakwaliteit: 83%
AVIR
Nasdaq Manufacturing Chemicals
€ 5,67
▼ € 0,17 (-2,91%)
Marktkapitalisatie: 461,30 M
Prijs
€ 5,79
Marktkapitalisatie
461,30 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -132,03 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-46,56%
Boven sectorgemiddelde (-53,34%)
ROIC-41,17%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio16,66
Interest CoverageN/A

Waardering

PE (TTM)
-2,91
Onder sectorgemiddelde (-1,47)
P/B Ratio1,46
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,9 -1,5
P/B 1,5 1,6
ROE % -46,6 -53,3
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

3 analisten
Buy
Huidig
€ 5,67
+55.8%
Koersdoel
€ 8,83
€ 6,00
€ 10,00
€ 10,50
Vooruitzicht
Forward K/W -4,09
Forward WPA -€ 1,39
Omzet Sch. 30,46 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 1,39
-€ 1,66 – -€ 1,11
 30,46 M 2
FY2026 -€ 1,93
-€ 2,20 – -€ 1,66
 0,0 2

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,49 -€ 0,57 -17,5%
Q32025 -€ 0,42 -€ 0,53 -27,7%
Q22025 -€ 0,42 -€ 0,44 -6,0%
Q12025 -€ 0,41 -€ 0,40 +2,6%

ETFs Holding This Stock

BRSIX BRSIX
0,41% weight
BRUSX BRUSX
0,11% weight
CSGEX CSGEX
0,08% weight
PSGIX PSGIX
0,08% weight
BDSCX BDSCX
0,04% weight
BDSIX BDSIX
0,04% weight
BDSKX BDSKX
0,04% weight
BDSAX BDSAX
0,04% weight
DLHIX DLHIX
0,04% weight
DLRHX DLRHX
0,04% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -158,35 M
ROE -46,56% ROA -43,11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -132,03 M
ROIC -41,17% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 16,66
Interest Coverage N/A Asset Turnover N/A
Working Capital 315,96 M Tangible Book Value 315,78 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,91 Forward P/E N/A
P/B Ratio 1,46 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -28,62%
Market Cap 461,30 M Enterprise Value 383,96 M
Per Share
EPS (Diluted TTM) -1,94 Revenue / Share N/A
FCF / Share -1,66 OCF / Share -1,66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 83,38%
SBC-Adj. FCF -160,89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 351,37 M 351,37 M
Net Income -158,35 M -168,39 M -135,96 M -115,91 M 121,19 M
EPS (Diluted) -1,94 -2,00 -1,63 -1,39 1,37
Gross Profit — — — — —
Operating Income -180,89 M -192,95 M -164,16 M -130,65 M 138,38 M
EBITDA — — — — —
R&D Expenses 148,02 M 144,10 M 114,24 M 81,94 M 167,21 M
SG&A Expenses — — — — —
D&A 416.000,0 416.000,0 416.000,0 260.000,0 29.000,0
Interest Expense — — — — —
Income Tax -6,16 M 925.000,0 1,02 M -3,59 M 17,40 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 315,22 M 464,67 M 594,97 M 666,71 M 772,89 M
Total Liabilities 39,78 M 25,80 M 39,78 M 26,14 M 62,82 M
Shareholders' Equity 275,43 M 438,87 M 555,19 M 640,57 M 710,08 M
Total Debt — — — — —
Cash & Equivalents 95,71 M 64,70 M 143,82 M 188,46 M 764,38 M
Current Assets 310,99 M 462,36 M 590,46 M 660,92 M 772,40 M
Current Liabilities 39,78 M 18,60 M 32,38 M 18,48 M 56,88 M